Back to Oncology Hub

CAR-T & Immunotherapy

China CD19 CAR-T cost advantage vs Kymriah; solid tumor trial access.

Medical highlights

CD19 CAR-T pricing; solid tumor trials

Target patients

Relapsed hematologic malignancy; advanced solid tumor trial seekers

Related guides & articles

From $80,000 USD (varies by regimen and center)

Get treatment plan and quote

Medical disclaimer

MediLink is a Medical Travel Coordinator, not a healthcare provider. Indications and regimens must be confirmed by MDT or your treating physician.